Skip to main content
OpenTrials
Completed

NCT Number: NCT02965534

Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality

Reduced quality of vision and glare in twilight or night are frequently mentioned complaints within the optometric examination. A reason for these problems could be a myopic refractive shift in dark light conditions, commonly known as night myopia or twilight myopia.

The aim of this study was to investigate whether quality of vision in twilight or night could be improved by a spectacle correction optimized for mesopic light conditions. Moreover, objective refraction in large pupils measured by aberrometry was compared to subjective mesopic refraction.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Degle Optometry, Augsburg, Bavaria, Germany

Loading trial locations.

About this study

After obtaining informed consent, aberrometry was performed in a darkened room (0.1 lux). Subjective photopic refraction and visual acuity were measured before light was turned off and mesopic refraction was obtained after a dark adaptation period of five minutes. Finally, frames and lenses were fitted by a centration system. Lens grinding was executed centralized by a grinding workshop. In the course of this study, subjects were randomly assigned to wear two glasses double-masked in turn. One with photopic subjective refraction data and another with mesopic subjective refraction data. Both were worn for 14 ± 2 days each.

Follow Up 1:

After two weeks, participants were asked for their subjective experiences with the first correction by a visual analogue scale questionnaire. After the evaluation, glasses were changed.

Follow Up 2:

Two weeks later, subjective experiences were evaluated again. After visual analogue scale questionnaire, subjects were asked to compare the two glasses concerning quality of mesopic vision and subjective safety level during night driving.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Visual Acuity at least 0.8 (5/6)
  • Binocular Vision

Exclusion criteria

  • refraction more than sph +/- 6 D and cyl 2 D
  • Difference between habitual correction and actual refraction more than 0.5 D
  • Medication with an influence on visual system
  • Disease or eye disease with an effect on the visual system
  • pregnancy or other hormonal variances
  • influence of drugs
  • mental handicap

Treatment and study plan

Spectacle/Glasses

Device

Primary outcomes

  1. Night Myopia

    Time frame: Baseline only

    Value of refractive shift (SE) when changing luminance from a photopic to a mesopic level.

    At Baseline, participants were not separated into arms as the Randomization Process was carried out at a later time point after participants picked up study glasses. Therefore, data are presented for All Participants in one Arm/Group.

Secondary outcomes

  1. Mesopic Visual Acuity Improvement

    Time frame: Baseline only

    Difference of visual acuity (monocular and binocular) in a darkened room (0.1 lux) after a dark adaption period of 5 min. with photopic spectacle correction ("classic" refraction obtained in photopic light conditions) compared to mesopic spectacle correction (correction of night myopia)

    Scale: logMAR visual acuity, using Landolt C optotypes.

    At Baseline, participants were not separated into arms as the Randomization Process was carried out at a later time point after participants picked up study glasses. Therefore, data are presented for All Participants in one Arm/Group.

  2. Subjective Vision Comfort in Dark Light Conditions

    Time frame: Test Period (4 weeks)

    Evaluation of subjective perceived vision comfort with the study and control glasses.

    Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

    Question:

    How would you evaluate vision comfort with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (insufficient) to 100 (very good)

  3. Subjective Vision Sharpness in Dark Light Conditions

    Time frame: Test Period (4 weeks)

    Evaluation of subjective perceived vision sharpness with the study and control glasses.

    Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

    Question:

    How would you evaluate vision sharpness with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (insufficient) to 100 (very good)

  4. Subjective Glare Sensitivity in Dark Light Conditions

    Time frame: Test Period (4 weeks)

    Evaluation of subjective perceived glare sensitivity with the study and control glasses.

    Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

    Question:

    How would you evaluate glare sensitivity with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (no glare) to 100 (strong glare)

  5. Subjective Driving Safety in Dark Light Conditions

    Time frame: Test Period (4 weeks)

    Evaluation of subjective perceived driving safety sense with the study and control glasses.

    Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

    Question:

    How would you evaluate driving safety sense when driving in twilight or night with the tested glasses? Answer: visual analogue scale slider from 0 (not safe) to 100 (very safe)

Sponsors and collaborators

Lead sponsor

University of Applied Sciences Jena

Other

Collaborators

  • IGA OPTIC EG

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Nov 16, 2016
Registry last updated
Feb 28, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.